Veli-Pekka Valkonen

Title: Veli-Pekka Valkonen: Innovator in Genetic Research

Introduction

Veli-Pekka Valkonen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of genetic research, particularly in the area of adrenoceptor proteins. His work has implications for understanding vascular conditions and potential treatments.

Latest Patents

Valkonen holds a patent for a DNA molecule encoding a variant α2B-adrenoceptor protein and its uses. This invention relates to a DNA sequence that comprises a nucleotide sequence encoding a variant α-adrenoceptor protein. It also includes a method for screening subjects to determine if they carry a variant gene that encodes this protein. Furthermore, the invention outlines a method for treating mammals suffering from vascular contraction of coronary arteries by administering a selective α-adrenoceptor antagonist. The patent also covers transgenic animals that contain a human DNA molecule encoding either the human α-adrenoceptor protein or the variant α-adrenoceptor protein. He has 1 patent to his name.

Career Highlights

Veli-Pekka Valkonen is associated with Oy Juvantia Pharma Ltd., where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies for cardiovascular diseases.

Collaborations

Valkonen collaborates with notable colleagues, including Amir Snapir and Paula Heinonen. Their combined expertise enhances the research efforts at Oy Juvantia Pharma Ltd.

Conclusion

Veli-Pekka Valkonen is a distinguished inventor whose work in genetic research is paving the way for innovative treatments in vascular health. His contributions are vital to the ongoing advancements in medical science.